Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US11103517 | EPI HLTH | Pharmaceutical compositions for minocycline |
Apr, 2036
(12 years from now) |
Minolira is owned by Epi Hlth.
Minolira contains Minocycline Hydrochloride.
Minolira has a total of 1 drug patent out of which 0 drug patents have expired.
Minolira was authorised for market use on 08 May, 2017.
Minolira is available in tablet, extended release;oral dosage forms.
The generics of Minolira are possible to be released after 07 April, 2036.
Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient
Market Authorisation Date: 08 May, 2017
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL